Open AccessGuidance for pharmacogenomic biomarker testing in labels of FDA-approved drugs
Author(s) -
Alexandre Vivot,
Isabelle Boutron,
Philippe Ravaud,
Raphaël Porcher
Publication year - 2014
Publication title -
genetics in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.509
H-Index - 128
eISSN - 1530-0366
pISSN - 1098-3600
DOI - 10.1038/gim.2014.181
Subject(s) - pharmacogenomics , medicine , genetic testing , biomarker , drug , oncology , medical prescription , pharmacogenetics , drug development , personalized medicine , pharmacology , bioinformatics , genotype , genetics , biology , gene
The aim of this study was to compare guidance for genetic testing in US Food and Drug Administration (FDA)-approved drug labels in oncology to those of drugs for other therapeutic areas.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom